Phase 1 study of TS-1 with Abraxane for metastatic breast cancer
Phase 1
- Conditions
- metastatic breast cancer
- Registration Number
- JPRN-UMIN000016377
- Lead Sponsor
- kyoto prefectural university of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
1)had a previous allergy for TS-1 or Abraxane 2)be pregnant or possible to pregnancy 3)with active breast cancer 4)with severe complications 5)with uncontrolled pleural effusion,ascites and edema 6)with brain metastasis 7)doctor's decision not to be registered to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method